UY26543A1 - INDAZOL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR MEASURING OR INHIBITING CELL PROLIFERATION. - Google Patents

INDAZOL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR MEASURING OR INHIBITING CELL PROLIFERATION.

Info

Publication number
UY26543A1
UY26543A1 UY26543A UY26543A UY26543A1 UY 26543 A1 UY26543 A1 UY 26543A1 UY 26543 A UY26543 A UY 26543A UY 26543 A UY26543 A UY 26543A UY 26543 A1 UY26543 A1 UY 26543A1
Authority
UY
Uruguay
Prior art keywords
cell proliferation
compounds
pharmaceutical compositions
methods
measuring
Prior art date
Application number
UY26543A
Other languages
Spanish (es)
Inventor
Siegfried Heinz Reich
Ted Michael Bleckman
Susan Elizabeth Kephart
Michael B Wallace
William Henr Y Romines Iii
Original Assignee
Agouron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agouron Pharma filed Critical Agouron Pharma
Priority to UY26543A priority Critical patent/UY26543A1/en
Publication of UY26543A1 publication Critical patent/UY26543A1/en

Links

Abstract

Se describen los compuestos de indazol que modulan y/o inhiben la proliferación celular tales como la actividad de las proteinquinasas. Estos compuestos y las composiciones farmacéuticas que los contienen son capaces de mediar, por ejemplo, en enfermedades quinasa dependientes para modular y/o inhibir la proliferación indeseada de células. El invento está también dirigido al uso terapéutico o profiláctico de composiciones farmacéuticas que contienen tales compuestos, y a métodos de tratar el cáncer así como otros estados de enfermedad asociados con angiogénesis indeseada y/o proliferación celular, tales como retinopatía diábetica, glaucoma neovascular, artritis reumatoide, y psoriasis, por medio de la administración de cantidades efectivas de tales compuestos.Indazole compounds that modulate and / or inhibit cell proliferation such as protein kinase activity are described. These compounds and the pharmaceutical compositions containing them are capable of mediating, for example, kinase-dependent diseases to modulate and / or inhibit undesired cell proliferation. The invention is also directed to the therapeutic or prophylactic use of pharmaceutical compositions containing such compounds, and to methods of treating cancer as well as other disease states associated with unwanted angiogenesis and / or cell proliferation, such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis , and psoriasis, through the administration of effective amounts of such compounds.

UY26543A 2001-01-18 2001-01-18 INDAZOL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR MEASURING OR INHIBITING CELL PROLIFERATION. UY26543A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UY26543A UY26543A1 (en) 2001-01-18 2001-01-18 INDAZOL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR MEASURING OR INHIBITING CELL PROLIFERATION.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UY26543A UY26543A1 (en) 2001-01-18 2001-01-18 INDAZOL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR MEASURING OR INHIBITING CELL PROLIFERATION.

Publications (1)

Publication Number Publication Date
UY26543A1 true UY26543A1 (en) 2001-08-27

Family

ID=38812319

Family Applications (1)

Application Number Title Priority Date Filing Date
UY26543A UY26543A1 (en) 2001-01-18 2001-01-18 INDAZOL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR MEASURING OR INHIBITING CELL PROLIFERATION.

Country Status (1)

Country Link
UY (1) UY26543A1 (en)

Similar Documents

Publication Publication Date Title
ECSP055858A (en) 2- (1H-INDAZOL-6-ILAMINO) - BENZAMID COMPOUNDS AS INHIBITORS OF USEFUL PROTEINKINASES FOR THE TREATMENT OF OPHTHALMIC DISEASES
DOP2001000120A (en) COMPOUNDS, PHARMACEUTICAL COMPOSITIONS OF INDAZOL AND METHODS TO MEASURE AND INHIBIT THE CELL PROLIFERATION
UY26190A1 (en) TIAZOLE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR INHIBITING PROTEINKINASES AND METHODS FOR THEIR USE
UY26231A1 (en) INDAZOLE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR THE INHIBITION OF PROTEIN KINASE AND METHOD FOR USE. UNDER LAW 17,164
ECSP066335A (en) INDAZOL 3,5-DISPOSED COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS TO INTERVENE IN OR INHIBIT THE CELL PROLIFERATION
GT200400136A (en) 3.5-DISPOSED INDAZOL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS TO INTERVENE IN OR INHIBIT CELLULAR APPROVALIFERATION.
TWI262914B (en) Compounds and pharmaceutical compositions for inhibiting protein kinases
GT200100014A (en) AMIDA COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS TO INHIBIT PROTEINKINASES, AND THEIR INSTRUCTIONS FOR USE.
UY26877A1 (en) PIRAZOL-TIAZOL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM, AND ITS INSTRUCTIONS FOR INHIBITING CYCLINE-DEPENDENT KINASES
UY26543A1 (en) INDAZOL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR MEASURING OR INHIBITING CELL PROLIFERATION.
PA8525701A1 (en) COMPOUNDS WITH HETEROCICLIC-HYDROXIMINE-FLUORENE NUCLEES AND PHARMACEUTICAL COMPOSITIONS FOR THE INHIBITION OF KINASE PROTEINS AND METHODS FOR USE
DOP2003000788A (en) INDAZOL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS TO INHIBIT PROTEINKINES, AND PROCEDURES FOR USE
ECSP003556A (en) INDAZOLE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR THE INHIBITION OF PROTEIN KINASE AND METHODS FOR USE
UY26667A1 (en) COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR INHIBITING PROTEIN KINASES
UY26888A1 (en) COMPOUNDS WITH HETEROCYCLIC-HYDROXIMINE-FLUORENE NUCLEUS AND PHARMACEUTICAL COMPOSITIONS FOR THE INHIBITION OF KINASE PROTEINS AND METHODS FOR USE
UY26547A1 (en) AMIDE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR INHIBITING PROTEINKINASES, AND THEIR METHOD OF USE
DOP2004000953A (en) INDAZOL COMPOUNDS 3,5-DISPOSED, PHARMACEUTICAL COMPOSITIONS AND METHODS TO INTERVENE IN OR INHIBIT THE CELL PROLIFERATION.

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20120524